Dramatic Response to Pyrotinib and T-DM1 in HER2-Negative Metastatic Breast Cancer With 2 Activating HER2 Mutations

Tian, H; Qu, M; Zhang, GZ; Yuan, L; Shi, QY; Wang, YH; Yang, Y; Zhang, Y; Qi, XW

Zhang, Y; Qi, XW (通讯作者),Army Med Univ, Southwest Hosp, Dept Breast & Thyroid Surg, Gaotanyan St 30, Chongqing 400038, Peoples R China.

ONCOLOGIST, 2023; 28 (7): E534

Abstract

HER2 signaling is activated in response to somatic HER2 mutations, which are often found in invasive lobular breast cancer (ILC) and are associated wi......

Full Text Link